BTSG — Brightspring Health Services Income Statement
0.000.00%
- $10.53bn
- $13.00bn
- $11.27bn
- 88
- 36
- 99
- 88
Annual income statement for Brightspring Health Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,580 | 6,698 | 7,721 | 8,826 | 11,266 |
| Cost of Revenue | |||||
| Gross Profit | 1,049 | 1,248 | 1,354 | 1,434 | 1,588 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 5,415 | 6,464 | 7,533 | 8,679 | 11,073 |
| Operating Profit | 165 | 234 | 188 | 147 | 194 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 26.2 | 68.9 | -45.8 | -177 | -34.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 21.2 | 51.3 | -54.2 | -157 | -20.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 20.8 | 49.8 | -53.9 | -155 | -18.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 20.8 | 49.8 | -53.9 | -155 | -18.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.343 | 0.496 | 0.136 | -0.372 | 0.269 |